Unlocking the Potential: Mineralys Therapeutics to Showcase Groundbreaking Research at Two November Conferences

Mineralys Therapeutics, Inc. (Nasdaq: MLYS) recently made a significant announcement regarding their upcoming poster presentations at two prestigious events in 2023 – ASN’s Kidney Week and AHA’s Scientific Sessions. The company, known for its focus on developing medicines to target hypertension and chronic kidney disease driven by abnormally elevated aldosterone, is set to present groundbreaking…

Read More

Unveiling the Thriving Bioscience Industry in Albuquerque: A Recap of the NM BioScience Industry at MedTech 2023 Conference

Albuquerque Regional Economic Alliance (AREA) Showcased NM Bioscience Industry at MedTech 2023 Conf… The Albuquerque Regional Economic Alliance (AREA) Shines Spotlight on New Mexico’s Bioscience Industry Albuquerque, NM, Oct. 13, 2023 (GLOBE NEWSWIRE) — The Albuquerque Regional Economic Alliance (AREA) was front and center at the Annual MedTech Conference held this week at the Anaheim…

Read More

Breaking News: Longeveron’s $4 Million Offering Closes with a Bang – All Thanks to Nasdaq Rules!

Welcome to the Longeveron Blog! Exciting News from Longeveron Inc. MIAMI, Oct. 13, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) Hey there Longeveron fans! Have we got some exciting news for you today! Longeveron Inc., a cutting-edge biotechnology company focused on developing cellular therapies for a range of life-threatening and chronic aging-related conditions, has…

Read More

Attention Investors: Don’t Miss Out on Your Chance to Take Action! Levi & Korsinsky Issues Class Action Lawsuit Alert for Kenvue Inc. (KVUE)

Welcome, Dear Reader! Let’s Talk About Kenvue Inc. and the Class Action Lawsuit Have you heard the latest news about Kenvue Inc.? Levi & Korsinsky, LLP has notified investors about a class action securities lawsuit involving Kenvue, the popular company traded on the New York Stock Exchange under the symbol KVUE. The lawsuit aims to…

Read More